a reprint of yesterday’s Nate’s Notes Inter-Issue Commentary Despite the fact that our fearless leaders in Washington just can’t seem to turn off the spigot when it comes to the flow of ineptitude they are demonstrating for the American people, … Continue reading →
And, speaking of MannKind (MNKD)… ***excerpted from Issue #225 of Nate’s Notes (dated 10/11/13)*** Though I have done my best to help keep subscribers focused on the idea that the story at MannKind (or any development stage drug company, for that matter) … Continue reading →
Note: the following is excerpted from the September 13th issue of Nate’s Notes, but since it does a great job of capturing the sentiment of the opening quote used in that issue (in bold below), we are posting it again now … Continue reading →
Some Questions on MannKind Answered By… MannKind! 8/27/13 (the following has been excerpted from a bulletin that was posted to the website this morning for subscribers of The Wagmore Advisory Letter) As I have discussed a couple of times now … Continue reading →
Some Thoughts on the Recent Action in MannKind’s Stock 8/19/13 (note: the following blog entry is a paraphrased and expanded-on update to a bulletin that was posted on the website for subscribers of The Wagmore Advisory Letter on 8/16/13) Well, in … Continue reading →